"Novartis will reimburse Mesoblast up to US$50 million on the achievement of certain milestones related tothe successful implementation of its next-generation manufacturing processes using its proprietary media and three-dimensional bioreactors aimed at delivering substantial manufacturing efficiencies"
I hope Novartis put a timetable on the 3D bioreactors for their milestone payments, otherwise they might be in for a long wait. These reactors have been a pipedream work in progress for MSB for the last 5 or 6 years.
Does anyone else have an inkling that this could have something to do with the recent joint announcement by Fujifilm and Lonza (MSB's CDMO) to collaborate on iPSC technology?
- Forums
- ASX - By Stock
- CYP
- Mesoblast and Novartis collaboration
Mesoblast and Novartis collaboration, page-6
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
21.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $39.74M |
Open | High | Low | Value | Volume |
22.0¢ | 22.0¢ | 21.5¢ | $12.79K | 59.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.210 |
3 | 17000 | 0.200 |
1 | 40000 | 0.195 |
5 | 66690 | 0.190 |
1 | 135135 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 5000 | 1 |
0.235 | 24281 | 1 |
0.240 | 19413 | 1 |
0.250 | 478 | 1 |
0.255 | 15000 | 1 |
Last trade - 15.19pm 24/09/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online